The QualityStocks Daily Stock List
- Empire Diversified Energy, Inc. (MPIR)
- MannKind Corporation (MNKD)
- Brightlane Corp. (BTLN)
- Heliospectra AB [publ] (HLSPY)
- StrikeForce Technologies, Inc. (SFOR)
- Saracen Mineral Holdings Limited (SCEXF)
- Isodiol International, Inc. (ISOLF)
- Monarques Gold Corporation (MRQRF)
- Flux Power Holdings, Inc. (FLUX)
- TechCare Corp. (TECR)
- Northstar Electronics, Inc. (NEIK)
- Novo Integrated Sciences, Inc. (NVOS)
- True Nature Holding, Inc. (TNTY)
- Aurion Resources Ltd. (AIRRF)
Empire Diversified Energy, Inc. (MPIR)
MarketWatch, Penny Stock Tweets, Dividend Investor, Biz Journals, OTC Markets, InvestorsHub, Morningstar, Investing, Stockhouse, Stockopedia, YCharts, Investors Hangout, PennyStockHub, EquityNet, OtcDynamics, and Hot Penny Stocks reported earlier on Empire Diversified Energy, Inc. (MPIR), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Empire Diversified Energy, Inc.’s principal goal is to serve the challenges of the energy Industry with unique solutions chiefly related to the safe removal and disposal of Coal Combustion Residue (CCR), normally referred to as coal ash, from the nation’s utilities storage ponds. In essence, Empire’s mission is to help clean up the existing environment and develop clean fuel sources in the future. Empire Diversified Energy is headquartered in Fort Lauderdale, Florida. The Company’s shares trade on the OTC Markets’ OTCQB.
At present, Empire Diversified Energy is initiating coal-reduction strategies involving increased use of sustainable biomass. Additionally, its longer-term plans will be to diversify into zero-emission fuel science and the widespread use of economically-viable hydro-electric, solar, as well as wind technologies.
The Company specializes in Diversified Green Energy projects. It is a full-service business. Empire provides strategic consulting and innovative environmental solutions to address industry issues including the above-mentioned CCR remediation and renewable energy alternatives. It has identified a niche market opportunity in the fly ash remediation sector.
Empire plans to acquire certain assets. These include, but are not limited to, logistical equipment, coal mines, landfills, solar equipment, and biomass inventories. This is because it is working to implement a vertical integration strategy.
The Company is currently developing a hybrid alternative fuel pellet (HAFP). The intention of HAFP is to allow utilities and other enterprises that now burn solid and gaseous fuel sources to transition from these traditional sources to HAFP’s. Empire is also developing its own proprietary binding agent. This binding agent will allow HAFP’s to be used across a wider spectrum of platforms.
HAFP’s are produced, in part, with high-grade reclaimed coal fines, blended with cellulose (wood) and/or other biomass material in an 80/20 configuration. Therefore, the resulting product is a cleaner, renewable fuel source with similar BTU output to pure coal.
Last month, Empire Diversified Energy announced it received the first tranche of investment funds from a private equity group. The funds have been used to pay off existing debt related to the Dickerson site in Cadiz, Ohio and to expand operations at the site.
The funding retired the remaining debt on the site that was acquired with the purchase of 100 percent of the membership rights of DTE Dickerson LLC, a Michigan LLC in April 2017. Moreover, the financing provides much needed working capital to expand the reclamation project. The debt is secured by all of the assets of Empire Minerals of Ohio Corporation, Empire Diversified Energy’s wholly-owned subsidiary and the operator of the Dickerson site, and 2 million shares of Empire Diversified Energy.
Empire Diversified Energy, Inc. (MPIR), closed Tuesday's trading session at $1.90, even for the day, on 1 volume with 1 trade. The average volume for the last 3 months is 9 and the stock's 52-week low/high is $0.80/$5.00.
MannKind Corporation (MNKD)
Stock Market Stop, Talk Traders, Zacks, InvestorsHub, Investor Place, Stock News, MarketWatch, Market Screener, Simply Wall St, Street Insider, Stockhouse, The Street, and Morningstar reported previously on MannKind Corporation (MNKD), and today we report on the Company, here at the QualityStocks Daily Newsletter.
MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products. These products are for patients with diseases such as pulmonary arterial hypertension and diabetes. Additionally, MannKind employs field sales and medical representatives across the U.S. A biopharmaceutical enterprise, the Company is headquartered in Westlake Village, California. It also has a state-of-the art manufacturing facility in Danbury, Connecticut.
MannKind is now commercializing Afrezza® (insulin human) inhalation powder. This is its first Food and Drug Administration (FDA)-approved product. Afrezza® is the only inhaled rapid-acting mealtime insulin in the U.S. It is available in the U.S. by prescription from pharmacies throughout the country.
Afrezza® uses the Company’s proprietary Technosphere® formulation technology. The foundation of this technology is on a class of organic molecules designed to self-assemble into small particles onto which drug molecules can be loaded. Afrezza® is available by prescription only. It is a fast-acting inhaled insulin used to improve glycemic control in adults with diabetes.
Afrezza® is taken at the start of a meal using the specially designed inhaler. One breath delivers one dose. Afrezza® dissolves rapidly upon inhalation to the deep lung. It delivers insulin quickly to the bloodstream. Peak insulin levels are achieved within 12 to 15 minutes of use and help to control post-meal blood sugar spikes that affect HbA1C levels.
For Q3 of 2018, Afrezza Net Revenue was $4.4 million. This represents an increase of 121 percent versus $2.0 million for Q3 of 2017. For the nine months ended September 30, 2018, Afrezza Net Revenue was $11.5 million. This represents an increase of 144 percent versus $4.7 million for the same period in 2017, reflecting increased product demand and pricing and also a more favorable mix of cartridges.
The Company’s inhalers efficiently focus the energy supplied by the patient’s breath directly onto the dry powder. This results in high delivery performance. MannKind’s single-use and reusable inhalers are breath-powered. Thus, they require only the patient’s inhalation effort to deliver the powder.
MannKind’s dry powder formulations are based on FDA-approved excipients. This includes fumaryl diketopiperazine (the excipient used in Technosphere® inhalation powders) and mannitol. The Company’s pipeline includes Epinephrine Technosphere® for anaphylaxis; and Treprostinil Technosphere® for Pulmonary Arterial Hypertension (PAH). Furthermore, MannKind’s pipeline includes Palonosetron Technosphere® for Chemotherapy-Induced Nausea and Vomiting (CINV).
Recently, United Therapeutics Corporation (UTHR) and MannKind announced the closing of their pending global exclusive license and collaboration agreement for the development and commercialization of Treprostinil Technosphere®, a dry powder formulation of treprostinil undergoing development for the treatment of pulmonary arterial hypertension. The effectiveness of the agreement was conditioned upon expiration or termination of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. The requisite waiting period expired on October 15, 2018. The agreement became effective the same day.
MannKind Corporation (MNKD), closed Tuesday's trading session at $1.74, up 1.16%, on 1,634,840 volume with 6,453 trades. The average volume for the last 3 months is 2,425,215 and the stock's 52-week low/high is $0.98/$4.05.
Brightlane Corp. (BTLN)
OTC Markets, Penny Stock Tweets, Market Exclusive, TradingView, Marketwired, Simply Wall St, Stockhouse, Barchart, 4-Traders, Morningstar, GuruFocus, MarketWatch, InvestorsHub, Capital Cube, YCharts, and Infront Analytics reported earlier on Brightlane Corp. (BTLN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Brightlane Corp. is a real estate operating company listed on the OTC Markets. It provides an alternative corridor to home ownership via a right-to-purchase program after meeting certain criteria. The Company focuses on acquiring, renovating, managing, and leasing low priced single-family homes chiefly in the United States. Brightlane has its corporate headquarters in Houston, Texas. The Company has its Operations Office in Atlanta, Georgia.
Brightlane’s acquisition efforts are primarily centered in the Southeast, Midwest, and Southwest regions of the United States. Its acquisition strategy is centered on multi-family housing - serving markets that include active senior living and Class A student housing. The Company is looking to expand its service offerings by way of acquisition and property management enhancement.
Brightlane provides opportunities in the affordable housing market. This includes reasonable rents and leases. At present, the Company acquires single-family homes and portfolios of single-family homes. It pursues the acquisition of these kinds of homes via one-off purchases, the purchase of portfolios, as well as other methods of acquisition.
Brightlane is looking for growth in ancillary markets. The Company is enhancing its business plan to access higher value and higher profit market segments with synergistic effects to its business model. It is working to expand its business model into different areas. These areas include multifamily, and the above-mentioned active adult living, and student housing.
Additionally, these areas include build-to-rent in the affordable housing space, non-performing notes, as well as credit reporting. Brightlane will also execute a ground up construction platform of rental single and multifamily products.
The Company announced in June 2018 that it reinforced its plans to expand its core technology development through the exploration of acquisition opportunities to further enhance its unique property value management services. The move will help to expedite the development of Brightlane’s proprietary, cloud-based platform to simultaneously manage single family, multifamily and student housing property operations.
This past July, Brightlane announced the launch of its newly redesigned website (brightlanecorp.com) as part of a brand refresh campaign started by the Company early this year. The Company stated that the new website is well positioned as a foremost source for insights, solutions, and interactive features for the property management industry. The new site has been optimized to ensure visitors are provided a premier user experience across all digital devices.
Brightlane Corp. (BTLN), closed Tuesday's trading session at $0.065, down 45.83%, on 6,592 volume with 3 trades. The average volume for the last 3 months is 2,668 and the stock's 52-week low/high is $0.039/$1.69.
Heliospectra AB [publ] (HLSPY)
Barchart, Equities.com, MarketWatch and OTC Markets reported on Heliospectra AB (HLSPY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Heliospectra AB (publ) specializes in intelligent lighting technology for plant research and greenhouse cultivation. The Company designs, develops, manufactures, and sells lighting systems in Sweden and around the world. Heliospectra is a global leader in intelligent lighting technology for horticulture controlled environments. The Company is based in Gothenburg, Sweden.
Heliospectra’s lighting system provides an effective and durable technology for cultivating greenhouse and indoor plants through uniting manifold different groups of versatile Light Emitting Diodes (LEDs) with optics, remote sensing techniques, and a strong heat dissipation solution. The Company provides smarter LED grow lights for commercial greenhouses, indoor grow facilities, and research applications.
Heliospectra’s patented solution enables growers to create customized lighting spectrum recipes. These recipes may be able to shorten a cannabis plant’s flowering cycle and even alter a strain’s balance of active cannabinoids.
The design and engineering of the Company’s highly-engineered Heliospectra Light System is to replace traditional lighting solutions in commercial greenhouse environments. For indoor grow facilities, its patented lighting system enables an operation to grow plants that look and taste better, have a longer shelf life, and increase the overall yield of its operation.
Heliospectra’s LED light systems make it possible to closely control the intensity of light wavelengths and to accurately match the spectrum to a particular plant. The spectral distribution of its systems (400nm to 735nm) is consistent with the action spectrum of photosynthesis and critical photomorphological receptors.
This past November, Heliospectra AB announced it was changing the name of the earlier announced light control software CORTEX to HelioCORE™, effective November 16, 2017. The new control system was introduced in July of 2017. It will be available for commercial sales during this Q1 2018. HelioCORE connects the Company’s LX60 adjustable spectra and LX50 high voltage intelligent LED lighting solutions with sensors and schedule functions for real-time light adjustments.
Furthermore, in November, Heliospectra announced that the Company was ranked the second-fastest growing technology company in Deloitte's prestigious Sweden Technology Fast 50. The Sweden Technology Fast 50 ranking includes public and private companies, large and small, in all areas of technology. The basis of the award is on Revenue growth over the last four years. Heliospectra came second with Revenue growth of 4 643 percent.
Last month, Heliospectra announced an order from a value-added reseller for a customer building a high-performance medicinal cannabis cultivation facility in Eastern Canada. The order for the Heliospectra LX60 intelligent LED lighting solution is valued at USD $651,200.
Heliospectra will demonstrate its intelligent lighting solutions, technical services, and new HelioCORE light control software at the upcoming Fruit Logistica event in hall 8.1 booth #B-16, February 7-9, 2018 in Berlin, Germany.
Heliospectra AB (HLSPY), closed Tuesday's trading session at $0.74, up 4.23%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 4,041 and the stock's 52-week low/high is $0.50/$1.20.
StrikeForce Technologies, Inc. (SFOR)
Stockopedia, Tip Ranks, OTC Markets, MarketWatch, Penny Stock Tweets, Barchart, YCharts, GuruFocus, Morningstar, The OTC Reporter, Capital Cube, Silicon Investors, Insider Financial, Simply Wall St, Investing, Investors Hangout, InvestorsHub, Street Insider, Nasdaq.com, and Stockhouse reported previously on StrikeForce Technologies, Inc. (SFOR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
StrikeForce Technologies, Inc. provides strong two-factor, “Out-of-Band” authentication, and keystroke encryption along with mobile solutions. The Company helps to prevent Cyber theft and data security breaches for consumers, corporations, as well as government agencies. StrikeForce Technologies has its corporate office in Edison, New Jersey. BlockSafe Technologies is a subsidiary company of StrikeForce Technologies.
StrikeForce’s three main products are ProtectID® (authentication), MobileTrust® (mobile device application), and GuardedID® (keystroke encryption). ProtectID® has a variety of potential authentications methods. These methods include Out-of-Band Phone; Out-of-Band Push; Hard Tokens; Mobile Tokens; and also Desktop Tokens.
MobileTrust® eliminates the threat from keylogging hackers. It does so through preventing them from detecting ones’ keystrokes. GuardedID® stops malicious keylogging programs. It does so through encrypting keystroke data and routing it directly to one’s internet browser or desktop through a secure pathway that is invisible to keyloggers.
StrikeForce provides the aforementioned “Out-of-Band Authentication” and “Endpoint Protection” using keystroke encryption, for signing on securely to one’s bank, broker, retail stores, and more. Furthermore, the Company provides mobile device security on one’s Apple or Android devices.
StrikeForce Technologies’ BlockSafe Technologies subsidiary concentrates on providing security solutions to protect blockchain and cryptocurrencies. BlockSafe Technologies will offer three uniquely redesigned security solutions. The first is Blockchain Defender™. The Company states that this will be the industry’s most completely dedicated Blockchain firewall.
The other two solutions are Desktop Defender™ and Mobile Defender™. These two products will protect digital wallets and cryptocurrencies on MS Windows, Apple, iOS, and Android platforms.
This past October, Veratad Technologies, LLC, an innovative and industry-leading provider of complete online tools to better know your customers and comply with federal regulations, announced it was chosen by BlockSafe Technologies to provide its identity verification and KYC/AML tools targeted at assisting BlockSafe with KYC and AML compliance efforts. BlockSafe Technologies has been granted licensing rights to implement and distribute the patented, award-winning cybersecurity technology offered by StrikeForce Technologies.
StrikeForce Technologies, Inc. (SFOR), closed Tuesday's trading session at $0.01499, down 3.29%, on 3,654,895 volume with 64 trades. The average volume for the last 3 months is 3,102,051 and the stock's 52-week low/high is $0.0047/$0.0255.
Saracen Mineral Holdings Limited (SCEXF)
Stockhouse, Gold Stock Data, OTC Markets, The Subway Trader, Smart Stock Trading Strategies, YCharts, 4-Traders, Stockscores, and Stock Market Watch reported earlier on Saracen Mineral Holdings Limited (SCEXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Saracen Mineral Holdings Limited engages in the gold mining business in Australia. In addition, it explores for nickel deposits. The Company’s production comes from two WA projects - Carosue Dam and its new Thunderbox mine. Both of these operations have long lives with wide-ranging potential for more growth via exploration. Saracen Mineral Holdings is based in Perth, Western Australia (WA).
The Company’s vision is to join the Australian mid-tier gold producer ranks through doubling production to 300koz p.a. at an AISC (All-in Sustaining Costs) of less than A$1,075/oz, within the next two years. Regarding its exploration, all of Saracen Mineral’s mines are open along strike and at depth. Additionally, all mines are shallow with grades increasing at depth.
Moreover, the Company has first-rate Reserve growth - a 40 percent increase to 2.1Moz at key assets next to processing centers. The Company’s Carosue Dam is surrounded by major miners Goldfields and AngloGold.
At Carosue Dam, an under-explored mine corridor presents opportunity for further repeat deposits. Production growth at Carosue Dam is through a potential mill expansion (to about 3Mtpa) and introduction of paste fill at the key underground mines to allow for close to full orebody extraction (improve mine
recoveries and efficiencies).
Growth opportunities at the Thunderbox mine include Kailis high grade (2.5g/t open pit, soft ore); Thunderbox Stage 2 underground (518koz over 7 years); Bannockburn (approximately 200koz @ 1.5g/t); as well as the Thunderbox D Zone (near surface northern cut-back).
On November 27, 2018, Saracen Mineral Holdings reported a drilling update including two new discoveries. The two discoveries highlight the potential of the Carosue Dam Corridor. The results will help support the strategy to increase inventory and boost production to 400,000ozpa.
The two new discoveries in the Carosue Dam Corridor are within 4km of the 2.4Mtpa mill. One discovery is Atbara – Discovery hole 40.0m @ 3.8g/t (including 12.0m @ 7.7 g/t). The other discovery is Qena – Discovery hole 20.0m @ 2.8g/t.
Saracen Mineral Holdings Limited (SCEXF), closed Tuesday's trading session at $2.05, up 6.22%, on 710 volume with 2 trades. The average volume for the last 3 months is 2,997 and the stock's 52-week low/high is $1.08/$1.98.
Isodiol International, Inc. (ISOLF)
Stockhouse, InvestorsHub, OTC Markets, Investopedia, and Wealth Daily reported on Isodiol International, Inc. (ISOLF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. An international Bioactive Phytoceutical innovator, the Company’s growth strategy includes the development of over-the-counter (OTC) and pharmaceutical drugs, and expanding its phytoceutical portfolio. Isodiol is continuing global expansion into Latin America, Asia, and Europe. OTCQB-listed, Isodiol International is headquartered in Vancouver, British Columbia.
The Company is the market leader in pharmaceutical grade phytochemical compounds. Furthermore, it is the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol International is the initiator of numerous firsts for the cannabis industry. This includes commercialization of 99 percent+ pure, bioactive pharmaceutical grade cannabinoids. It also includes micro-encapsulations and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol International produces raw ingredients, consumer packaged goods such as dietary supplements, food and beverages, skin care, and pharmaceutical products for the worldwide healthcare market. Regarding raw ingredients, the Company develops natural phytoceutical derivatives and delivery technologies.
Concerning consumer products, it develops its own family of product brands for retail sale. It also develops white label products and brands for wholesale customers. Pertaining to pharmaceuticals, Isodiol supplies raw phytoceutical ingredients.
Isodiol International Inc announced this month the U.S. sales launch of ImmunAG™. This product is the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, therefore creating greater bioactivity.
Isodiol has acquired worldwide licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.
With this innovative non-systemic delivery system, a topical cream can be applied to the back of the neck (at the hairline). It is subsequently picked up by the free nerve endings in the dermis of the skin for a highly effective delivery of the compound.
Last week, Isodiol International announced that it entered into a definitive agreement in connection with its earlier announced Letter of Intent (LOI) to acquire Bradley’s Bioscience, Inc. Bradley’s is a foremost manufacturer and distributer of hemp oil and nicotine e-liquids.
Mr. Marcos Agramont, Isodiol International’s Chief Executive Officer, said, “The acquisition of Bradley’s Bioscience, a market poised to be a $61.4 billion-dollar industry by 2025 is another major milestone for the Company. Not only does this allow the Company to penetrate a new market, but we are now also able to provide consumers with a safer alternative to smoking. Overall, we believe Bradley’s Bioscience is a perfect fit with Isodiol and our long-term vision and we are very pleased to be moving forward with this agreement.”
Furthermore, Isodiol International has entered into a binding agreement to acquire 100 percent of C3 Global Biosciences (C3GBS). C3GBS is a cause driven organization. Its dedication is to developing sustainable health solutions via the advancement of cannabis science.
Isodiol International, Inc. (ISOLF), closed Tuesday's trading session at $1.3397, up 9.81%, on 324,371 volume with 322 trades. The average volume for the last 3 months is 153,621 and the stock's 52-week low/high is $0.7833/$14.19.
Monarques Gold Corporation (MRQRF)
The National Investor, Northern Vertex, Canadian Insider, Barchart, Junior Mining Network, 4-Traders, Mining & Energy, Northern Miner, Private Capital News Wire, Stockhouse, YCharts, and 24hgold reported previously on Monarques Gold Corporation (MRQRF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Monarques Gold Corporation is a developing gold producer based in Montreal, Quebec. The Company’s focus is on pursuing growth by way of its large portfolio of high-quality projects in the Abitibi mining camp in Quebec. Monarques formerly went by the name Monarques Resources, Inc. It changed its name to Monarques Gold Corporation in January 2015. Monarques Gold lists on the OTC Markets.
The Company owns close to 300 km² of gold properties. These include the Beaufor Mine, the Croinor Gold, Wasamac, McKenzie Break and Swanson advanced projects. In addition, Monarques owns the Camflo and Beacon mills, and six promising exploration projects. Furthermore, it offers custom milling services out of its 1,600 tonne-per-day Camflo mill.
The Beaufor Mine had production of 5,444 ounces of gold in Q2 2018. This represents an increase of 61 percent since its acquisition from Richmont Mines. Annual production at Beaufor is +20K ounces. The Beaufor Mine has strong drilling results. This includes 61.48 g/t Au over 3.9 m. There is excellent potential to increase the resource at Beaufor.
Recently, Monarques Gold reported its results in CDN$ for Q1 ended September 30, 2018. Highlights include Revenues of $7.8 million in Q1 from the sale of 3,272 ounces of gold combined with Revenue from custom milling that increased by 16 percent during the quarter. The Company had a Net Loss of $1.9 million or $0.008 per share, diluted, versus a Net Loss of $0.5 million or $0.003 per share, diluted, the year prior.
Last week, Monarques Gold reported positive results from the Feasibility Study (FS) prepared by BBA, Inc. for the Wasamac Gold project, positioned 15 km west of Rouyn-Noranda, in Abitibi, Quebec. The results of the FS show that Wasamac is an economically viable project expected to be a low-cost producing mine. Moreover, the FS provides the foundation for making a production decision. It also serves to totally support the permitting and financing processes.
Mr. Jean-Marc Lacoste, President and Chief Executive Officer of Monarques Gold, said, "The feasibility study is based on a top-down mining approach and the use of the Rail-Veyor® system through a twin-ramp access and haulage facility, which eliminates the hefty initial capital expenditures associated with building a shaft, increases flexibility in mine planning, shortens the timeline to production and allows us to significantly decrease the overall cost of the project. We also believe that we will be able to extend the Wasamac mine life, as the deposit remains largely underexplored at depth and along strike.”
Monarques Gold Corporation (MRQRF), closed Tuesday's trading session at $0.184, down 6.12%, on 14,009 volume with 7 trades. The average volume for the last 3 months is 21,728 and the stock's 52-week low/high is $0.108/$0.35.
Flux Power Holdings, Inc. (FLUX)
Penny Stock Pick Alert, Penny Stock Pick Report, PennyPickAlerts, PennyStockMoneyTrain, RisingPennyStocks, StockMister, Marketbeat.com, The Wall Street Transcript, Stock News Now, PennyStocks24, Tip.us, Catalyst IR, Joe Penny Stocks, Liquid Tycoon, Super Hot Penny Stocks, Super Nova Stock Picks, WePickPennyStocks, Winning Penny Stock Picks, Lebed.biz, Wall Street Grand, and Greenbackers reported earlier on Flux Power Holdings, Inc. (FLUX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Flux Power Holdings, Inc. is a developer of advanced lithium batteries for industrial applications. This includes its first-ever UL 2771 Listed lithium-ion "LiFT Pack" forklift batteries. The Company develops and markets advanced lithium-ion energy storage systems (batteries) founded on its proprietary battery management system (BMS) and in-house engineering and product design. OTCQB-listed, Flux Power Holdings is based in Vista, California.
Flux’s storage solutions deliver improved performance, extended cycle life, and greater return on investment (ROI) than legacy solutions. The Company’s products include advanced battery packs for motive power in the lift equipment, tug and tow, and robotics markets, portable power for military applications, and also stationary power for grid storage.
Applications include Motive Power, Portable Power, and Stationary Power. Motive Power includes Lift Pack - Class III Walkie Trucks and Lift Pack - Tug & Tow Pack. Pertaining to Portable Power, Flux Portable Packs consist of lithium-ion battery cells that are managed and operated by its proprietary Battery Management System (BMS), all contained in lightweight, strong, and easily maneuvered cases.
The design of Flux Power’s LiFT Pack solution is for walkie pallet jack forklifts, extensively utilized in warehouses and depots, on trucks, and at retail locations. The Company has developed a 72 volt, 400 Ah battery pack to power electric aviation ground support equipment, initially baggage tow tractors using the same proprietary technology found on the LiFT Pack line for small forklifts.
Flux Power Holdings stated that this additional channel for lithium technology is a natural extension for the Company in its broader goal of serving a variety of industrial markets. In doing so, the Company expects to capture the benefits of building bigger and more expensive equipment. This includes better economies of scale and higher financial margins.
Regarding the Flux battery model: LiFT-24V, it offers up to a 5 times longer lifespan andup to a 25 percent longer run time. It also offers higher sustained power during every work shift. It is maintenance-free and fewer batteries are required for multi-shift applications.
Flux Power Holdings, Inc. (FLUX), closed Tuesday's trading session at $1.65, even for the day, on 1,190 volume with 4 trades. The average volume for the last 3 months is 4,220 and the stock's 52-week low/high is $0.277/$3.35.
TechCare Corp. (TECR)
InvestorsHub, OTC Markets, Investing.com, Barchart, Stockhouse, 4-Traders, GuruFocus, PennyStockTweets, Investors Hangout, and Emerging Growth reported on TechCare Corp. (TECR), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, TechCare Corp. has an innovative delivery platform that uses vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this unique delivery platform utilizing vaporization of different natural, plant-based compounds, to enable a wide assortment of treatment solutions. A technology enterprise, TechCare is based in New York, New York.
TechCare has a strategic partnership agreement with HoMedics, one of the world's leading brands in health and wellness products. HoMedics will manufacture, market, and distribute TechCare's Novokid products in the United States, Canada, Brazil, Argentina, Colombia, and Costa Rica. The products will be co-branded as HoMedics products powered by TechCare.
Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap.
Novokid is the first of its type home use device. It presents a scientifically proven solution to eliminate lice, super lice, and eggs. Novokid is 100 percent natural, plant-based and pesticide-free. Novokid uses a proprietary vapor-based delivery platform. TechCare’s Novokid has received CE Mark approval as a CLASS I Medical Device.
Novokid uses a simple 10 minute dry treatment. The treatment requires no rinsing or washing. The treatment is fast, dry, and clean.
Furthermore, it is easily administered at home or while mobile. In addition, Novokid can be used as a maintenance and preventative treatment if used regularly.
Last month, TechCare announced that it signed its first distribution agreement with MWMedical B.V. for TechCare's Novokid lice treatment device, which addresses a $1.8 billion international market, and a European market estimated to exceed $500 million. MWMedical is a foremost distributor of medical devices in the Netherlands.
This multi-year agreement grants the distributor exclusive distribution rights in the Netherlands in consideration of minimum purchase commitments. The distributor has placed its first order of Novokid's products, 2,500 kits. They will be available in the Netherlands this month. The Netherlands represents the first success for TechCare among 28 European countries that the Company can sell to following the receipt of CE Approval.
Zvi Yemini, TechCare’s Chairman, said, "TechCare is delighted to announce its first agreement for Novokid with MWMedical to provide TechCare's leading technology with the broad representation of this organization in Netherlands. We are proud that after a wide-ranging evaluation, MWMedical has selected TechCare's technology. Beginning in February, the Dutch market will now have wide access to the superior Novokid lice treatment device."
TechCare Corp. (TECR), closed Tuesday's trading session at $0.122, up 1.67%, on 1,620 volume with 3 trades. The average volume for the last 3 months is 2,592 and the stock's 52-week low/high is $0.109/$0.75.
Northstar Electronics, Inc. (NEIK)
Front Page Stocks, Stockhouse, MarketWatch, Marketwired, and OTC Watch reported on Northstar Electronics, Inc. (NEIK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Northstar Electronics, Inc. is working in the aviation, defense, and marine industries. The Company has an extensive history of developing and manufacturing defense and commercial electronic and mechanical systems. Northstar formed in the late 1990’s. It carried out design and manufacturing contracts for different divisions of Lockheed Martin Corp. In addition, it designed, manufactured, and sold its own sonar-based system to commercial customers. Northstar Electronics lists on the OTC Markets’ OTCQB. The Company has its corporate office in Virginia Beach, Virginia.
Northstar Electronics has moved towards making and selling its own independent systems, since the termination of the above contracts. Northstar Electronics is now undergoing restructuring to go forward with a renewed emphasis on the development of a new aviation business as well as carry out work to develop unique sonar systems.
Northstar Electronics earlier stated that its subsidiary, Northstar Sealand Enterprises Ltd. (NSEL), is working to acquire the global rights to a “Turbo-Prop” single engine industrial airplane from an international leader in the aerospace industry. The timeline for the final agreement with the subsidiary company, which owns the rights to the airplane, has been extended.
Dr. Wilson Russell, Northstar Electronics’ Chief Executive Officer, said, “Although the timeline to an agreement has been extended, the potential resulting benefits are highly significant to Northstar. It also means that we would likely have the support of the parent company for up to five years going forward. "
The main applications for the airplane are in “Agriculture and Rapid Response Forest Fire Fighting.” Northstar Sealand Enterprises is continuing its assessment of the “Cloud Seeding” market. Company Management believes the new design features of the NSEL airplane will rapidly lead to it being a leader in its class.
Upon the signing of the airplane “Rights Acquisition Agreement”, Northstar Sealand Enterprises’ intention is to launch its plans to start the actions leading to manufacturing the airplane and marketing it around the world.
Subsidiary Northstar Sealand Enterprises registered in 2014. It is jointly owned by Northstar Electronics and Sealand Aviation Ltd. Both companies have numerous years of experience in working with certified commercial aircraft and government military contracts.
Northstar Sealand Enterprises is finalizing arrangements to assemble, certify, manufacture, service, repair, and market the new turboprop single engine commercial aircraft in Canada, for the global market, beginning with the North, South, and Central American markets at first. Work is moving ahead on the prototype aircraft.
Northstar Electronics, Inc. (NEIK), closed Tuesday's trading session at $0.01, up 11.11%, on 18,000 volume with 2 trades. The average volume for the last 3 months is 35,767 and the stock's 52-week low/high is $0.0052/$0.015.
Novo Integrated Sciences, Inc. (NVOS)
OTC Markets, InvestorsHub, Corporateinformation.com, TradingView, Stockhouse, MarketWatch, Simply Wall St, Stock Orange, InvestorPlace, and Investing News Alerts reported on Novo Integrated Sciences, Inc. (NVOS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Novo Integrated Sciences, Inc. is a provider of multi-disciplinary primary healthcare services and products in Canada through its wholly-owned Canadian subsidiary Novo Healthnet Limited (NHL). The Company’s mission is to build a United States and Canadian based multi-disciplinary primary healthcare service provider, which provides first-class specialized healthcare services and products via the integration of technology and medical science.
Novo Integrated Sciences lists on the OTC Markets Group’s OTCQB. Novo Integrated Sciences was formerly known as Turbine Truck Engines, Inc., which was an alternative-energy technology development enterprise. Novo Integrated Sciences is based in Bellevue, Washington.
The Novo Family provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, and massage therapy. In addition, it provides acupuncture, chiropodist, neurological functions, kinesiology, certain dental assessments, certain long-term care services, and other para-medical services to its clients.
Novo Healthnet Limited (NHL) - directly and indirectly, through its contractual relationships - provides its specialized services to greater than 300,000 patients annually. The Novo Family's services include pain assessment, treatment, management, and prevention. These are provided in 14 corporate owned clinics, homes, and institutional locations across Canada.
NHL owns a 100 percent stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited, Novo Peak Health, Inc., and an 80 percent stake in Novo Healthnet Kemptville Centre, Inc., all of which are Province of Ontario companies.
Novo Integrated Sciences announced in December of 2017 that it completed the purchase of certain assets of Executive Fitness Leaders (EFL). EFL is an Ottawa, Ontario based local leader in the private personal training sector. EFL provides personal training, massage therapy, nutritional counseling, and also corporate wellness services.
Last month, Novo Integrated Sciences, via its wholly-owned U.S. based subsidiary, Novomerica Health Group, Inc., a Nevada corporation, announced a signed Letter of Intent (LOI) to acquire Illinois Spine and Disc Institute, Ltd. (ISDI) and Progressive Health and Rehabilitation, Ltd. Both of these entities are Illinois headquartered medical care corporations dedicated to the diagnosis, treatment, as well as rehabilitation of peripheral neuropathy related spine and neck disorder. The pending acquisition transaction definitive agreement is contemplated as a share only transaction. It has a closing date of no later than June 1, 2018.
Novo Integrated Sciences, Inc. (NVOS), closed Tuesday's trading session at $2.20, up 4.27%, on 7,150 volume with 7 trades. The average volume for the last 3 months is 30,116 and the stock's 52-week low/high is $0.1135/$2.99.
True Nature Holding, Inc. (TNTY)
InvestorsHub, Real Pennies, MarketWatch, Marketwired, Stockhouse, and OTC Markets reported on True Nature Holding, Inc. (TNTY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
True Nature Holding, Inc.’s business plan considers a roll-up of businesses in the compounding pharmacy industry. The plan contemplates numerous acquisitions of businesses, which have conventionally operated locally, but that have specialty formulations that may have a larger market. The Company is targeting the acquisition of pharmacies that serve the human, and in some cases, pet markets. True Nature Holding is based in Atlanta, Georgia.
True Nature Holding has acquired 100 percent of the membership interests of Newco4pharmacy, LLC. Newco4pharmacy is a development stage business targeted at creating a network of compounding pharmacies.
The Company’s concentration is on the consolidation of the compound pharmacy industry. Its plan is to acquire a series of businesses that specialize in compounding pharmacy activities, principally direct to consumers, and to doctors and veterinary professionals. Pharmaceutical compounding is performed in compounding pharmacies. It is the creation of a specific pharmaceutical product to fit the exclusive need of a patient.
True Nature is creating a blend of human and veterinary businesses, and a balance of cash oriented operations, and more usual insurance based operations. It expects to create three operating subsidiaries to hold its planned acquisitions, while maintaining its current holding company structure for the publicly held entity. The expectation is that all the new subsidiaries will be wholly-owned, single member LLC's, controlled and managed by the public company.
True Nature Holding is launching a new initiative targeted at supporting the need for lower cost pharmaceuticals within the medically underserved small town and rural marketplaces. Its intention is to create a joint venture (JV) for-profit subsidiary; True Nature Community Health, Inc. This will be owned by the public company, and a newly formed not-for-profit entity; The True Nature Community Health Foundation.
True Nature Holding is in the process of acquiring the newly formed subsidiary, True Nature Community Health, Inc. (Community Health Subsidiary). It will have an 80 percent ownership in the Community Health Subsidiary. The remaining 20 percent ownership will be held by not-for-profit organizations with purposes of enhancing the availability of compounded drugs and other pharmaceuticals to medically underserved rural communities, or advancing social enterprise businesses that aim to address community health needs in similar areas.
True Nature Holding’s intention is to move ahead with its plans to enter the retail pharmacy space by way of "mini-stores" situated within smaller, second tier grocery sites. The Company believes that those sites centered on the Hispanic market represent excellent, underserved market opportunities. To determine the best strategy, True Nature is analyzing data from industry experts.
True Nature Holding, Inc. (TNTY), closed Tuesday's trading session at $0.085, up 1.75%, on 11,744 volume with 3 trades. The average volume for the last 3 months is 53,382 and the stock's 52-week low/high is $0.0315/$0.1995.
Aurion Resources Ltd. (AIRRF)
Gold Stock Data, Stockscores, MoneyHub, Stockwatch, Barchart, The Street, Wallmine, Gold Telegraph, Market Screener, Investor Point, Penny Stock Hub, Stockhouse, Investors Guru, Dividend Investor, Wallet Investor, and 4-Traders reported earlier on Aurion Resources Ltd. (AIRRF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Aurion Resources Ltd. is an exploration company listed on the OTC Markets. Its strategy is to generate or acquire early stage precious metals exploration opportunities and advance them through business partnerships or joint venture (JV) arrangements. Incorporated in 2006, Aurion Resources has its head office in St. John’s, NL (Newfoundland and Labrador).
Currently, Aurion’s emphasis is on developing its projects in Finland where it has a JV arrangement with B2 Gold Corp. Aurion Resources started a gold exploration initiative in the Central Lapland Greenstone Belt (CLGB) of Northern Finland in 2014. The Company controls roughly 200,000 ha of mineral tenements within the Paleoproterozoic, CLGB.
Aurion Resources’ initial acquisition was the purchase of the Kutuvuoma and Silasselka projects from Dragon Mining Oy. After that, it independently acquired more mineral tenements throughout the CLGB. Present total land holdings are now approximately 70,000 hectares.
Kutuvuoma is a high-grade gold project. Kutuvuoma occurs along a multi-km structural-stratigraphic trend associated with the regional Sirkka Shear Zone. Silasselka was discovered by the state mining entity Otanmaki Oy in the 1960s. Silasselka lies north of and along trend with the Hanhimaa Shear Zone that hosts numerous gold occurrences to the south. No exploration has taken place since the 1960s. Furthermore, no gold exploration is documented.
Today, Aurion Resources provided an update on drilling results at Aamurusko on its Risti Project in northern Finland. Selected highlights include 17.1 g/t Au over 1.80 m in drillhole 75, 80 m down plunge of drillhole 42 (789 g/t Au over 2.9 m). Highlights also include 2.0 m of an 8.2 m wide vein in drillhole 77 contained visible gold (assays pending) 25 m up plunge of hole 42.
Moreover, gold mineralization with an apparent steeply dipping shoot geometry was intersected in 5 drillholes over a down plunge distance of 110 m at Aamurusko. Drilling has stopped for the holiday season break. It will continue in January 2019.
Mr. Mike Basha, President and Chief Executive Officer of Aurion Resources, said, “The predicted auriferous vein intercepts in drillholes 75 and 77 have greatly enhanced our understanding of the structural controls at Aamurusko. The discovery of gold mineralization in trenching and drill core in multiple targets over a distance of more than 8 km suggests the mineralizing system at Aamurusko and Risti in general may have considerable scale. Almost every drillhole to date at Risti has encountered some gold mineralization, supporting this…”
Aurion Resources Ltd. (AIRRF), closed Tuesday's trading session at $0.78, up 9.52%, on 79,991 volume with 106 trades. The average volume for the last 3 months is 14,415 and the stock's 52-week low/high is $0.516/$1.744.
The QualityStocks Company Corner
- Net Element, Inc. (NASDAQ: NETE)
- Earth Science Tech, Inc. (ETST)
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- Aziza Project LLC
- Zenergy Brands, Inc. (ZNGY)
- Marijuana Company of America Inc. (MCOA)
- Youngevity International, Inc. (NASDAQ: YGYI)
- Icon Exploration Inc. (TSX.V: IEX.H)
- Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
- CytoDyn Inc. (CYDY)
Net Element (NASDAQ: NETE)
Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, announces the launch of Netevia Light POS, seamless and secure mobile payments acceptance software on smart terminals by PAX Technology. Also today, NetworkNewsWire released a report on the company detailing how NETE is one of North America’s 500 fastest growing companies in 2018, as it’s ranked by Deloitte’s Technology Fast 500 (http://nnw.fm/rUki5). Over the period for which the ranking accounts, Net Element grew by 183 percent.
Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.
Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.
With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.
Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.
“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”
Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.
Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:
- Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
- Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
- Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
- Payonline – A fully integrated, processor agnostic electronic commerce platform.
Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.
“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”
Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.
Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.
From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.
Net Element (NETE), closed the day's trading session at $7.68, up 3.91%, on 80,722 volume with 486 trades. The average volume for the last 3 months is 304,723 and the stock's 52-week low/high is $3.75/$33.51.
- Net Element Launches Netevia Light POS on Android-Based Smart Payment Terminals
- Net Element, Inc. (NASDAQ: NETE) Included among North America’s 500 Fastest Growing Companies
- 420 with CNW – Why Cannabis Capsules are Gaining Popularity
Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that as the Company is now an “OTC reporting issuer” in the Province of Québec, Canada, its board of directors is considering a dual listing of its common shares on the Canadian Securities Exchange (CSE). Also today, the company was highlighted in an article from Financialnewsmedia.com, explaining that the CBD niche of the cannabis sector has been growing at a stupendous rate, as CBD-based products rapidly gain popularity.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.67, up 8.06%, on 38,097 volume with 50 trades. The average volume for the last 3 months is 122,977 and the stock's 52-week low/high is $0.421/$2.45.
- Earth Science Tech, Inc. (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE)
- Emphasis on Developing Rare Cannabinoids-CBD Products Proving Valuable for Medicinal Marijuana Industry
- Earth Science Tech, Inc. (ETST) Eyes Growth and Anticipates Hygee Device Certification in 1Q2019; Sets Launch of Two Nutraceutical Products
Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)
Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) was highlighted in an article today from Financialnewsmedia.com, examining how attention surrounding the cannabis market continues to be accentuated by the industry’s astonishing growth rate as it continues to flourish in light of legalization across the globe and now, major tobacco focusing on cannabis opportunities. Also today, the company announced two executive additions to the recently-formed Ontario Retail Team: Lamar Hanna as Senior Vice President Retail, Ontario and David Schenk, Regional Operations Manager, Ontario. Choom was also pleased to announce an update of its Ontario retail strategy in which 90 offers to lease are currently under negotiation, with 20 leases secured.
Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.
Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.
True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.
Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.
A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.
While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.
Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.4454, up 18.88%, on 1,351,244 volume with 523 trades. The average volume for the last 3 months is 391,631 and the stock's 52-week low/high is $0.198/$1.129.
- Cannabis’ Rising Momentum Attracting Attention From Major Tobacco as Multi-Billion Dollar Market Swells
- Choom Strengthens Ontario Retail Leadership
- Choom Expands into Medical Cannabis Channel with the Acquisition of Clarity Cannabis Medical Centres
Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)
Phivida Holdings Inc. (CSE: VIDA OTCQX: PHVAF) ("Phivida" or the "Company"), today announced that they have appointed Covet Public Relations (Covet PR) as its national U.S. public relations agency of record, effective immediately. Covet PR, an award-winning public relations agency with offices in San Diego, New York City and San Francisco, will handle Phivida's communications efforts in the U.S. to support the visibility of the Oki lifestyle brand (www.feeloki.com) – the company's recently launched line of functional beverages and supplements infused with active hemp extract.
Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.
The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.
Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.
Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.
Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.
Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.
Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.
Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.
The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.
The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.
In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.
3 Wholly Owned Subsidiaries
- Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
- Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
- Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.
Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.
Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.
Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.
Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).
+1 (844) 744-6646 (ext. #2)
Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.505, up 4.68%, on 5,706 volume with 9 trades. The average volume for the last 3 months is 97,930 and the stock's 52-week low/high is $0.05/$1.80.
- Phivida appoints Covet Public Relations as U.S. Public Relations Agency of Record
- NetworkNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) to Benefit from Progressive Developments in the Cannabis Sector
- Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Keeps its Vision High as Cannabis Prospects Continue to Germinate through Political Changes
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted today in an article explaining how distinct advantages are appearing in each region of the emerging cannabis market. Leading the pack are the state of California, and the entire country of Canada, which each have their own favorable regulations to adhere to for a growing class of ambitious cannabis companies.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.09, up 1.75%, on 465,175 volume with 315 trades. The average volume for the last 3 months is 749,587 and the stock's 52-week low/high is $0.939/$2.79.
- Distinct Regional Advantages Emerging for Pacific Northwest in Blossoming Cannabis Sector
- 420 with CNW – Supply Shortages Could Delay Issuance of Cannabis Retail Licenses in Alberta
- Supreme Cannabis and Khalifa Kush Enterprises Announce International Partnership
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was featured today in a report from CannabisNewsWire explaining how a quarter-three report for 2018 released by the Treasury Department’s FinCEN (Financial Crimes Enforcement Network) shows that the number of financial institutions that are doing business with marijuana businesses has increased by 20 percent from what it was at the start of this year.
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.65, up 0.48%, on 201,789 volume with 154 trades. The average volume for the last 3 months is 427,812 and the stock's 52-week low/high is $0.519/$3.293.
- 420 with CNW – Federal Report Shows More Banks Doing Business with Cannabis Companies
- Canna Farms Wins Top Reviewed Licensed Producer of the Year Award
- VIVO Cannabis™ Reports Record Revenue for Q3 2018
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) was pleased to provide a progress report as it awaits award of the Continuous Use Permit from the City of Desert Hot Springs for its 9.55 acre property inlocated in the City’s cannabis cultivation-friendly zone. Also today, the company was highlighted in an article explaining how distinct advantages are appearing in each region of the emerging cannabis market. Leading the pack are the state of California, and the entire country of Canada, which each have their own favorable regulations to adhere to for a growing class of ambitious cannabis companies.
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements’ expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company “maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S.”
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree’s working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.39163, off by 3.30%, on 149,947 volume with 130 trades. The average volume for the last 3 months is 19,315 and the stock's 52-week low/high is $0.268/$0.7158.
- Chemistree Provides Corporate Update
- Distinct Regional Advantages Emerging for Pacific Northwest in Blossoming Cannabis Sector
- Early Winners Emerging in American Cannabis “Green Rush”
Aziza Project LLC
The QualityStocks Daily Newsletter would like to spotlight Aziza Project LLC.
Oil majors are still a-goggle at the huge gas reserves discovered in Mozambique and Tanzania over the past decade. The 160 trillion cubic feet (TCF) of recoverable gas in the Rovuma Offshore Basin of Mozambique is on par with Nigeria’s 180 TCF and Algeria’s 160 TCF. The 57 TCF reserve in Tanzania’s Mafia Deep Basin, though not quite as big, is substantial enough to merit investment. As a result, Africa has definitely gotten its fair share of attention, and some of the largest players in the oil industry – ExxonMobil, Royal Dutch Shell, British Petroleum – are acquiring assets and stepping up exploration activities (http://ibn.fm/5b3oX). The Aziza Project plans to do the same.
Aziza Project LLC is a fund that tokenizes high potential oil and gas businesses in Africa, enabling them to raise funds for profit and social good. Aziza Project and its tokenization approach aims to address the obstacles associated with traditional fundraising by taking advantage of the benefits of blockchain technology to eliminate the cost and need for middlemen and complex administration. Aziza Project’s token, the Aziza Coin, is an asset-backed mid-to-long-term security token.
The vision for Aziza Project’s primary business is to light up Africa, bringing electricity to the 630 million people who currently have no access to the grid and typically depend on wood and paraffin for their energy needs, and in the process to deliver excellent returns to investors.
Through Aziza Coin, Aziza Project owns 20% of Africa New Energies (ANE), which holds rights to a 22,000-square-kilometer prospective hydrocarbon concession in Namibia. This potentially world-scale oil and gas deposit in eastern Namibia, bordering Botswana and the Kalahari Desert, could transform the region’s energy supply and provide a powerful boost to growth in Namibia. By using big data algorithms, the ANE project will be developed at a fraction of the cost of traditional methods.
In 2017 ANE rejected a $500 million unsolicited bid in the belief that this prime asset can deliver far more for investors, the local community and the people of Africa. The bid rejection has been superseded by an innovative fundraising model to unlock the value that ANE data indicates is under the ground. This sparked the genesis of Aziza Project, the creation of an oil and gas fund set up to raise capital to take ANE and other high potential oil and gas businesses to the next level smartly and efficiently.
Aziza Project is seeking to raise $60 million through the sale of Aziza Coins, an asset-backed security token compliant with the Ethereum blockchain’s ERC20 standard. The asset, a 20 percent interest in ANE, is estimated to be worth $100 million based on the value of the unsolicited bid. Funding raised by the Aziza Coin Initial Coin Offering, which began in October 2018, will be used to finance a 10 well drilling program for ANE’s Namibian concession and to develop an oil and gas fund. Proving a hydrocarbon resource will result in significant value creation for Aziza Coin holders. Proving of the project’s estimated 1.6 billion barrels of oil equivalent resource could value ANE at $3.1 billion, which would result in Aziza Project’s holding to potentially be worth up to $620 million.
The Aziza Coin seeks to create significant investor value that marries a compelling business case with the efficiency of crypto. People who buy Aziza Coins will have an indirect fractional ownership of the assets held by Aziza Project. And with tokens listed on exchanges, investors will have a degree of liquidity that private company shareholders do not have and with greater access to real returns. Aziza Coin token holders are the sole economic beneficiaries of Aziza Project’s investments and are assured that at least 51 percent of funds will be used to buy back tokens anytime a profit is made in a calendar year.
Typical investment funds charge a myriad of fees and administrative charges. These will not be present within Aziza Project LLC, with no annual fees, exit fees or salary expenses. The vision is to get as much of the investor’s dollar into the assets under management, and then on exit get as much of the asset value back to the investor. Aziza Project believes that tokenization of assets and securities is the future. Distributed ledger technology will be the catalyst for the benefit of both investors and businesses forging their way.
The Aziza Coin ICO is different because its management team is very clear on valuations and laser-focused on the broader objective established by Aziza Project. The Aziza Coin is an asset-backed security token with a strong management team grounded in blue-chip corporate backgrounds and established real-world businesses.
CEO Robert Pyke has a professional background that covers consumer goods, consultancy and now cryptocurrency. Much of his career was spent at Unilever where he worked in a variety of finance roles, rising to become finance director for Unilever’s €20bn turnover Beauty and Personal Care division.
Aziza Project co-founder Shakes Motsilili has an Investments Administration background and worked for several years at Momentum Wealth as head of Actuarial Support. He resigned in 2012 to become an entrepreneur with a vision to electrify the whole of Africa.
Brendon Raw, CTO, is a South Africa-based software developer and investor in the energy technology, property and digital media sectors. Brendon was lead developer on the sales and revenue system of the one of the most valuable internet companies of its day – excite@home and was BP’s tactical application developer, creating several mission-critical commodity trading systems.
- Aziza Project LLC to Develop $100 Million Interest in Namibian Claims as Oil Majors Dash into Southern Africa
- The Road to Becoming a Security Token: Featuring Aziza Coin
- Aziza Project LLC Offers Investors an Opportunity to Support Rebirth of Hydrocarbon Industry in Southern Africa
Zenergy Brands, Inc. (ZNGY)
Serving commercial, industrial and municipal customers, Zenergy Brands, Inc. (OTC: ZNGY) specializes in reducing utility consumption courtesy of its innovative Zero Cost Program. The company’s vision is to enhance businesses via responsible energy use and management. Zenergy’s Zero Cost Program enables customers to reduce utility consumption at no out-of-pocket cost. Also today, NetworkNewsWire released a report highlighting the company. To view the full article, visit: http://nnw.fm/8Iv1O.
Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.
The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.
A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.
Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.
Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.
“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.
On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.
Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0002, up 100.00%, on 288,787,313 volume with 19 trades. The average volume for the last 3 months is 30,654,325 and the stock's 52-week low/high is $0.00009/$0.0189.
- Zenergy Brands, Inc. (ZNGY) Helps Businesses Reduce Utilities Consumption via its Zero Cost Program
- NetworkNewsBreaks – Zenergy Brands, Inc.’s (ZNGY) Smart Home Technologies Deliver Customizable Efficiency Settings to Residential Customers
- NetworkNewsBreaks – Zenergy Brands, Inc.’s (ZNGY) Market Reach Expands as the Accessibility of Innovative Technologies Increases
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America Inc. (MCOA) pleased to announce the launch of a new corporate hempSMART™ website and marketing platform for its associates.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0174, up 20.00%, on 15,430,254 volume with 449 trades. The average volume for the last 3 months is 9,654,333 and the stock's 52-week low/high is $0.0115/$0.0728.
- Marijuana Company of America Announces New hempSMART™ Website and Sales Platform
- CannabisNewsAudio Announces Audio Press Release (APR) on Marijuana Company of America, Inc. Recognizing Opportunities in Industry Set for Tremendous Growth
- CannabisNewsWire Announces Recent Washington, D.C., Changes Pave Way for Opportunity for Hemp and Cannabis Producers
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International, Inc. (NASDAQ: YGYI) was featured today in a report from CannabisNewsWire explaining how a quarter-three report for 2018 released by the Treasury Department’s FinCEN (Financial Crimes Enforcement Network) shows that the number of financial institutions that are doing business with marijuana businesses has increased by 20 percent from what it was at the start of this year.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.25, off by 2.34%, on 128,307 volume with 730 trades. The average volume for the last 3 months is 566,534 and the stock's 52-week low/high is $3.167/$16.25.
- 420 with CNW – Federal Report Shows More Banks Doing Business with Cannabis Companies
- Youngevity International, Inc. (NASDAQ: YGYI) Presents at LD Micro Main Event, Co-Founder Dr. Joel Wallach Featured in Globally-Viewed Documentary
- Youngevity International, Inc. (NASDAQ: YGYI) Focusing on Multiple Product Verticals
Icon Exploration Inc. (TSX.V: IEX.H)
Icon Exploration Inc., a publicly traded company on the NEX Exchange (TSXV: IEX.H) whose primary objective is to create a well-diversified company that produces long-term returns for its shareholders and investors by focusing on assessing potential acquisition targets in the cannabis industry, today announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW").
Icon Exploration Inc.'s (TSX.V: IEX.H) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
Icon Exploration Inc. (TSX.V: IEX.H), closed the day's trading session at $0.41, even for the day, on 86,680 volume. The stock's 52-week low/high is $0.15/$0.84.
- Coverage Initiated for Icon Exploration Inc. (TSXV: IEX.H) via NetworkNewsWire
- Icon Exploration Inc. (TSX.V: IEX.H) is “One to Watch”
- Icon Exploration Inc. Executes Formal Share Exchange Agreement in Furtherance of its Change of Business Transaction
Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G), a client of NNW focused on becoming the leading supplier to the cannabis beverage and edibles market. The interview can be heard at http://nnw.fm/o6H35.
Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.311, off by 4.31%, on 258,282 volume with 155 trades. The average volume for the last 3 months is 171,256 and the stock's 52-week low/high is $0.189/$1.875.
- Sproutly Canada, Inc. Discusses Innovation and Expansion in Exclusive Audio Interview with NetworkNewsWire
- Sproutly Announces Hiring New President from Anheuser-Busch InBev and Kimberley Clark
- Disruptive Marijuana Beverage Stock Has Exposure to a $4.4 Billion Market
CytoDyn Inc. (CYDY)
CytoDyn Inc. (OTCQB: CYDY), a biotechnology company focused on the development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV), expects to gain final FDA approval for its HIV treatment, PRO 140, by the fourth quarter of 2019, with market availability estimated to follow by 2020.
CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.
PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.
CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.
HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.
PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.
The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.
PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.
As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.
In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.
The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.
CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.
CytoDyn Inc. (CYDY), closed the day's trading session at $0.54, off by 5.26%, on 251,576 volume with 72 trades. The average volume for the last 3 months is 201,665 and the stock's 52-week low/high is $0.40/$0.836.
- CytoDyn, Inc. (CYDY) Expects FDA Approval for PRO 140 in HIV by Q4 2019, $500M Revenue Forecast for 2020
- NetworkNewsBreaks – CytoDyn Inc. (CYDY) to Host Conference Call, Provide Business Update on December 12, 2018
- CytoDyn’s Prostate Cancer Prognostic Test Demonstrates Substantial Added Value to Gleason Score in Predicting Patient Outcomes
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Aziza Project LLC to Develop $100 Million Interest in Namibian Claims as Oil Majors Dash into Southern Africa
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference
- Cannabis Strategic Ventures, Inc. (NUGS) Works Toward 20 Licenses for 250,000 square feet of Cannabis Cultivation: Begins Large California Growth
- Canopy Rivers Inc. (TSXV: RIV) 420 with CNW – Cannabis PTSD Study Finally Secures Target Number of Participants
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) Provides Corporate Update
- ChineseInvestors.com (CIIX) featured on MoneyTV with Donald Baillargeon, 12/7
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Cannabis’ Rising Momentum Attracting Attention From Major Tobacco as Multi-Billion Dollar Market Swells
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cyberfort Software, Inc. (CYBF) Aims to Develop Modern Cybersecurity Solutions Following Planned Acquisition
- CytoDyn Inc. (CYDY) Expects FDA Approval for PRO 140 in HIV by Q4 2019, $500M Revenue Forecast for 2020
- DPW Holdings, Inc. (NYSE American: DPW) Coolisys Technologies Receives $1.3 Million in Repeat Contracts
- Earth Science Tech, Inc. (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE)
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Advances Final Tranche for Buildout of Refined Resin Facility
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Continues Intercepting High-Grade Mineralization at Iron Creek Cobalt Project
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Vision System Installed in Leading Automotive OEM’s Vehicle
- Generation Alpha, Inc. (GNAL) CannabisNewsAudio Announces Audio Press Release (APR) on Generation Alpha Positioned to Become Strong Competitor Among Cannabis Support Companies
- Global Payout, Inc. (GOHE) Completes Two Year Financial Audit, Plans to File Form 10 by Year End
- Golden Developing Solutions, Inc. (DVLP) Dispensary Tips Help Set the Stage for the Success of its Greener Grows Software Division
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Millennial Consumers Drive the Market for Craft Marijuana
- GTX Corp (GTXO) Provides Q3 2018 Financial Summary
- Icon Exploration Inc. (TSX.V: IEX.H) Coverage Initiated via NetworkNewsWire
- Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Coverage Initiated via NetworkNewsWire
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Expanding Personnel, Issues Stock Options
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Provides Corporate Update and Announces Expansion to its Helados Prospect
- Marijuana Company of America Inc. (MCOA) Announces New hempSMART™ Website and Sales Platform
- Medical Cannabis Payment Solutions (REFG) Payment System Delivers Secure, Convenient Transactions
- Net Element, Inc. (NASDAQ: NETE) Launches Netevia Light POS on Android-Based Smart Payment Terminals
- NUGL Inc. (NUGL) Scales Broad Launch Into the Cannabis Industry
- Pacific Software, Inc. (PFSF) Hyperledger Blockchain Technology Could Facilitate Tense Trades by Tracking Complex Transactions
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) appoints Covet Public Relations as U.S. Public Relations Agency of Record
- Plus Products Inc. (CSE: PLUS) With Strategic Acquisition, Plus Products Expands Capacity & Offering -- CFN Media
- Pressure BioSciences Inc. (PBIO) New Management Hire to Play Key Role in Advancing Company’s Commercialization Programs, Revenue Growth
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Advances Lithium Project as Potential Supply Deficits Approach
- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) Reports Three Executives Are Set to Speak at Vancouver O’Cannabiz 2018
- RYU Apparel Inc (TSX.V: RYU) (OTC: RYPPF) (FRA: RYA) Supports 2018 Canada's Walk Of Fame as Premier Partner
- Sharing Services, Inc. (SHRV) Prepares for Future Growth Ahead of Elepreneurs 2.0 Launch
- SinglePoint, Inc. (SING) Expects Record Revenue in 2018, Announces New Strategic Developments
- Spectrum Global Solutions, Inc. (SGSI) Presented Company Plans for 2019 at LD Micro Main Event
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Discusses Innovation and Expansion in Exclusive Audio Interview with NetworkNewsWire
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) New Battery Developments Leading To Innovative Energy Metals Extraction
- Sugarmade, Inc. (SGMD) is Introducing Brands to Disrupt the Cannabis Industry
- Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) Announces Resignation of Natural Health Services Ltd. President
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Distinct Regional Advantages Emerging for Pacific Northwest in Blossoming Cannabis Sector
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corp. (TSX.V: FLWR) Holds a Unique Advantage Over its Competitors
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) Announces 2018 AGM Voting Results
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) 420 with CNW – Missouri Welfare Recipients Uncertain Whether Medical Cannabis Will Affect Benefits
- TransCanna™ Set to Get Marijuana Moving Across California ‘Pot Desert’ Landscape
- United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) United Battery Metals Update
- Victory Marine Holdings Corp. (VMHG) Aims to Offer Tailored Customer Care Following Sales
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Federal Report Shows More Banks Doing Business with Cannabis Companies
- Youngevity International, Inc. (NASDAQ: YGYI) 420 with CNW – Federal Report Shows More Banks Doing Business with Cannabis Companies
- Zenergy Brands, Inc. (ZNGY) Helps Businesses Reduce Utilities Consumption via its Zero Cost Program
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.